Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
GO Therapeutics logo — Opening the Therapeutic Window for antibody-based cancer the...

GO Therapeutics

Opening the Therapeutic Window for antibody-based cancer therapies

Founded 2014 United States Natick, United States 9 employees Biotechnology, Health Care +1

General Information

Company Name GO Therapeutics
Founded Year 2014
Location United States Natick, United States
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with GO Therapeutics. To contact GO Therapeutics, visit gotherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GO Therapeutics compare?

A PDF of GO Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GO Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GO Therapeutics

GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a new class of cancer therapies for previously intractable solid tumors. We target O-linked glycoproteins specific to cancer cells to develop proprietary, high-affinity antibodies to novel cancer-specific targets. Our antibodies are the basis for a broad array of potent cancer-killing modalities including T-cell bispecifics (TCBs), CAR-T, and antibody drug conjugates (ADCs). Each are designed to kill cancer while sparing healthy tissue.

No funding data available for GO Therapeutics yet.

GO Therapeutics Alternatives & Competitors

View All Alternatives
GO Therapeutics vs
ONA Therapeutics
ONA Therapeutics Spain

First-in-class ADCs tailored to attack advanced cancer

Series A
43 employees
Biotechnology, Health Care
GO Therapeutics vs
Bright Biologics
Bright Biologics United States

Developing bispecific antibody drug to improve cancer treatment.

6 employees
Biotechnology, Health Care
GO Therapeutics vs
ImmunoBiochem Corporation
ImmunoBiochem Corporation Canada

Improving patient outcomes through innovations in biological therapeutics

Seed
4 employees
Biotechnology, Health Care
View all alternatives

FAQ About GO Therapeutics

Opening the Therapeutic Window for antibody-based cancer therapies
GO Therapeutics was founded in 2014.
GO Therapeutics is headquartered in Natick, United States.
GO Therapeutics operates in Biotechnology, Health Care and Pharmaceutical.
GO Therapeutics has approximately 9 employees.
Top alternatives and competitors to GO Therapeutics include ONA Therapeutics, Bright Biologics, ImmunoBiochem Corporation, Acepodia, Akari Therapeutics, Plc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GO Therapeutics and ONA Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GO Therapeutics, https://bouncewatch.com/company/go-therapeutics, updated 16 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout